Evidence map›Paper›PMID 38856686›Full record

ReviewClinical microbiology reviews2024

Ouli Xie, Mark R Davies, Steven Y C Tong

Abstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Clinical and Molecular Characteristics ofOpen forum infectious diseases · 2026
    Article
  2. Review
  3. Article
  4. Streptococcal toxic shock syndrome caused by ST525 Streptococcus dysgalactiae subsp. equisimilis with genomic characterization of virulence and antimicrobial resistance.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Genomic and patient epidemiology ofMicrobiology spectrum · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Microorganisms · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Analysis ofmBio · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ouli XieDepartment of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0000-0002-5032-1932
Mark R DaviesDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0000-0001-6141-5179
Steven Y C TongDepartment of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0000-0002-1368-8356

Funding

Avant Foundation (The Avant Foundation) 2021/000017National Health and Medical Research Council GNT2013831
6 · The paper itself

Abstract

SUMMARY

Indexed as

Streptococcal InfectionsStreptococcusStreptococcus pyogenesVirulence FactorsAnti-Bacterial AgentsGenome, BacterialHumansWhole Genome SequencingAnti-Bacterial AgentsVirulence Factorsgroup C/G StreptococcusStreptococcusStreptococcus dysgalactiaeStreptococcus pyogenes

Identifiers

PMID38856686
PMCPMC11392527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.